Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Early Bird Registration Expires

DAYS

HOURS

MINUTES

SECONDS

Send Email 1.888.257.6457

返回 Agenda

Session 3: Evolution of DTC Promotion

Session Chair(s)

Anthony Genovese, PharmD

Group Leader, Regulatory Advertising and Promotion

Johnson and Johnson, United States

Lynn Bowen, PhD

Vice President, Regulatory Affairs Advertising Promotion & Labeling

Alkermes, Inc., United States

This engaging session will explore the dynamic landscape of direct-to-consumer (DTC) promotion, highlighting current trends and future implications. Industry experts will provide insights into the evolving DTC strategies, particularly in response to regulatory changes and technological advances.

Learning Objective :
Examine the digital transformation in DTC strategies, including social media advertising
Evaluate the complexities in assessment of CFL claims for consumer audiences
Apply best practices related to broadcast ads and identify broadcast-like technologies where similar principles may apply

Speaker(s)

Best Practices for Broadcast Ads in the CCN Era

Representative Invited

Opus Regulatory Inc, United States